U.S. markets open in 31 minutes
  • S&P Futures

    3,696.00
    -13.00 (-0.35%)
     
  • Dow Futures

    29,583.00
    -86.00 (-0.29%)
     
  • Nasdaq Futures

    11,361.00
    -15.75 (-0.14%)
     
  • Russell 2000 Futures

    1,679.90
    -6.20 (-0.37%)
     
  • Crude Oil

    78.77
    +0.03 (+0.04%)
     
  • Gold

    1,653.10
    -2.50 (-0.15%)
     
  • Silver

    18.84
    -0.07 (-0.34%)
     
  • EUR/USD

    0.9671
    -0.0017 (-0.17%)
     
  • 10-Yr Bond

    3.7750
    +0.0780 (+2.11%)
     
  • Vix

    32.06
    +4.71 (+17.22%)
     
  • GBP/USD

    1.0885
    +0.0028 (+0.26%)
     
  • USD/JPY

    143.8710
    +0.5510 (+0.38%)
     
  • BTC-USD

    19,073.55
    -25.96 (-0.14%)
     
  • CMC Crypto 200

    437.63
    -6.91 (-1.55%)
     
  • FTSE 100

    6,956.04
    -62.56 (-0.89%)
     
  • Nikkei 225

    26,431.55
    -722.28 (-2.66%)
     

A UpHealth, Inc. (NYSE:UPH) insider increased their holdings by 0.4% last year

·3 min read

Viewing insider transactions for UpHealth, Inc.'s (NYSE:UPH ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

View our latest analysis for UpHealth

UpHealth Insider Transactions Over The Last Year

The Co-Founder Mariya Pylypiv made the biggest insider purchase in the last 12 months. That single transaction was for US$102k worth of shares at a price of US$3.42 each. That means that an insider was happy to buy shares at above the current price of US$0.72. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Mariya Pylypiv was the only individual insider to buy shares in the last twelve months.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

UpHealth is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does UpHealth Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It's great to see that UpHealth insiders own 65% of the company, worth about US$68m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About UpHealth Insiders?

There haven't been any insider transactions in the last three months -- that doesn't mean much. On a brighter note, the transactions over the last year are encouraging. Judging from their transactions, and high insider ownership, UpHealth insiders feel good about the company's future. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. For example - UpHealth has 3 warning signs we think you should be aware of.

But note: UpHealth may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here